Swine Reproductive and Respiratory Syndrome Vaccine Market

Swine reproductive and respiratory syndrome is an acute and highly contagious viral infection characterized by reproductive disorder and respiratory symptoms in pig population.

Swine Reproductive and Respiratory Syndrome Vaccine Market contains market size and forecasts of Swine Reproductive and Respiratory Syndrome Vaccine in global, including the following market information:

Global Swine Reproductive and Respiratory Syndrome Vaccine Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Swine Reproductive and Respiratory Syndrome Vaccine Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Swine Reproductive and Respiratory Syndrome Vaccine companies in 2021 (%)

The global Swine Reproductive and Respiratory Syndrome Vaccine market was valued at 436.7 million in 2021 and is projected to reach US$ 838.1 million by 2028, at a CAGR of 9.8% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Active Vaccine Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Swine Reproductive and Respiratory Syndrome Vaccine include ASCENT CORPORATION, Boehringer-Ingelheim, MSD Animal Health, SPAH, Ceva, Chengdu TECH-BANK Biological Products Co,.Ltd, ringpu, QILU ANIMAL HEALTH PRODUCTS CO.,LTD and DAHUANONG, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Swine Reproductive and Respiratory Syndrome Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Swine Reproductive and Respiratory Syndrome Vaccine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Swine Reproductive and Respiratory Syndrome Vaccine Market Segment Percentages, by Type, 2021 (%)

Active Vaccine

Inactivated Vaccines

Global Swine Reproductive and Respiratory Syndrome Vaccine Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Swine Reproductive and Respiratory Syndrome Vaccine Market Segment Percentages, by Application, 2021 (%)

Government Tender

Market Sales

Global Swine Reproductive and Respiratory Syndrome Vaccine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Swine Reproductive and Respiratory Syndrome Vaccine Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Swine Reproductive and Respiratory Syndrome Vaccine revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Swine Reproductive and Respiratory Syndrome Vaccine revenues share in global market, 2021 (%)

Key companies Swine Reproductive and Respiratory Syndrome Vaccine sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Swine Reproductive and Respiratory Syndrome Vaccine sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

ASCENT CORPORATION

Boehringer-Ingelheim

MSD Animal Health

SPAH

Ceva

Chengdu TECH-BANK Biological Products Co,.Ltd

ringpu

QILU ANIMAL HEALTH PRODUCTS CO.,LTD

DAHUANONG

CAVAC

Komipharm

Agrovet

Bioveta

JINYU BIO-TECNOLOGY CO.,LTD

Phibro Animal Health

ANHUI TIANKANG(GROUP)SHRES O., LTD

Zoetis

WINSUN BIO

PULIKE BIOLOGICAL ENGINERING,INC.